Stress Intervention for Chronic Urticaria

This study has been completed.
Sponsor:
Information provided by:
University of Mississippi Medical Center
ClinicalTrials.gov Identifier:
NCT01111136
First received: April 23, 2010
Last updated: November 23, 2010
Last verified: November 2010

April 23, 2010
November 23, 2010
March 2010
July 2010   (final data collection date for primary outcome measure)
Urticaria Activity Score [ Time Frame: 7 weeks ] [ Designated as safety issue: No ]
Measures the daily level of skin itching and the number of hives as the study progresses.
Same as current
Complete list of historical versions of study NCT01111136 on ClinicalTrials.gov Archive Site
Level of stress. [ Time Frame: 7 weeks ] [ Designated as safety issue: No ]
A set of questionnaires done before the first session and after the sixth/final session will be done to compare level of stress.
Same as current
Not Provided
Not Provided
 
Stress Intervention for Chronic Urticaria
Effect of Psychological Stress Intervention for Patients With Chronic Urticaria

Stress and chronic urticaria has been linked. The purpose of the study is to evaluate a patients chronic urticaria and stress levels before and after he/she goes through six sessions designed to help that participant manage his/her stress.

The purpose of this single-arm, interventional pilot study is to evaluate the effect of psychological stress intervention for patients with chronic urticaria, as many of these patients report heightened levels of stress before and/or after the onset of the urticaria. Participants will meet individually with a University of Mississippi Medical Center psychiatry resident for one hour once a week for six consecutive weeks to be educated on psychological stress intervention techniques. There is no control group for this pilot study. All participants will complete a packet of psychological and dermatological questionnaires before the first session with the psychiatry resident and one week after the final session. All participants will record daily 1) their urticaria symptoms and 2) the type and number of medications taken for his/her chronic hives. If psychological stress intervention proves to be effective, then this therapeutic modality would benefit patients with chronic urticaria, while avoiding addition and/or continuation of medications that may have significant adverse side effects.

Interventional
Not Provided
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Primary Purpose: Treatment
Chronic Urticaria
Behavioral: Stress intervention
To evaluate psychological stress, participants will complete the Perceived Stress Scale, Beck Depression Inventory-Fast Screen, Anxiety Sensitivity Index-III, Posttraumatic Stress Diagnostic Scale and the Depression Anxiety Stress Scales; to evaluate cognitive and behavioral aspects of emotional avoidance, participants will complete the Emotional Avoidance Questionnaire as well as the Acceptance and Action Questionnaire, Difficulties in Emotion Regulation Scale, Illness Attitudes Scale and the Five Facet Mindfulness Questionnaire; and to evaluate quality of life in regards to his/her skin condition, participants will complete the Dermatology Life Quality Index questionnaire.
Experimental: stress intervention
Stress intervention.
Intervention: Behavioral: Stress intervention

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
4
July 2010
July 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Males and females age 18-64 years old who have had hives for longer than 6 weeks.
  • Hives persist despite medical therapy.
  • Minimum Urticaria Activity Score of 2 (one point from each of the two categories: number of hives and severity of pruritus).

Exclusion Criteria:

  • Urticaria secondary to vasculitis.
  • Urticaria as part of an anaphylactic response.
  • Use of Omalizumab within 3 months preceding enrollment period.
Both
18 Years to 64 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01111136
2010-0052
No
John W. Tole, D.O., University of Mississippi Medical Center
University of Mississippi Medical Center
Not Provided
Principal Investigator: John W. Tole, D.O. University of Mississippi Medical Center
Study Director: Gailen D. Marshall, MD, PhD University of Mississippi Medical Center
University of Mississippi Medical Center
November 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP